Mental Illness Drugs Market
1 Mental Illness Drugs Market Overview
1.1 Product Overview and Scope of Mental Illness Drugs
1.2 Mental Illness Drugs Segment by Type
1.2.1 Global Mental Illness Drugs Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Antipsychotics
1.2.3 Antidepressants
1.2.4 Antianxiety (anxiolyitcs)
1.2.5 Anti-seizure medications
1.2.6 Stimulants
1.2.7 Cognitive disorders and dementia
1.2.8 Sleep disorder treatments
1.2.9 Substance abuse treatments
1.3 Mental Illness Drugs Segment by Application
1.3.1 Global Mental Illness Drugs Sales Comparison by Application: (2023-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drugstore
1.4 Global Mental Illness Drugs Market Size Estimates and Forecasts
1.4.1 Global Mental Illness Drugs Revenue 2018-2030
1.4.2 Global Mental Illness Drugs Sales 2018-2030
1.4.3 Mental Illness Drugs Market Size by Region: 2018 Versus 2022 Versus 2030
2 Mental Illness Drugs Market Competition by Manufacturers
2.1 Global Mental Illness Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Mental Illness Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Mental Illness Drugs Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Mental Illness Drugs Manufacturing Sites, Area Served, Product Type
2.5 Mental Illness Drugs Market Competitive Situation and Trends
2.5.1 Mental Illness Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Mental Illness Drugs Players Market Share by Revenue
2.5.3 Global Mental Illness Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mental Illness Drugs Retrospective Market Scenario by Region
3.1 Global Mental Illness Drugs Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Mental Illness Drugs Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Mental Illness Drugs Market Facts & Figures by Country
3.3.1 North America Mental Illness Drugs Sales by Country
3.3.2 North America Mental Illness Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Mental Illness Drugs Market Facts & Figures by Country
3.4.1 Europe Mental Illness Drugs Sales by Country
3.4.2 Europe Mental Illness Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Mental Illness Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Mental Illness Drugs Sales by Region
3.5.2 Asia Pacific Mental Illness Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Mental Illness Drugs Market Facts & Figures by Country
3.6.1 Latin America Mental Illness Drugs Sales by Country
3.6.2 Latin America Mental Illness Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Mental Illness Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Mental Illness Drugs Sales by Country
3.7.2 Middle East and Africa Mental Illness Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Mental Illness Drugs Historic Market Analysis by Type
4.1 Global Mental Illness Drugs Sales Market Share by Type (2018-2023)
4.2 Global Mental Illness Drugs Revenue Market Share by Type (2018-2023)
4.3 Global Mental Illness Drugs Price by Type (2018-2023)
5 Global Mental Illness Drugs Historic Market Analysis by Application
5.1 Global Mental Illness Drugs Sales Market Share by Application (2018-2023)
5.2 Global Mental Illness Drugs Revenue Market Share by Application (2018-2023)
5.3 Global Mental Illness Drugs Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Johnson and Johnson
6.1.1 Johnson and Johnson Corporation Information
6.1.2 Johnson and Johnson Description and Business Overview
6.1.3 Johnson and Johnson Mental Illness Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Johnson and Johnson Mental Illness Drugs Product Portfolio
6.1.5 Johnson and Johnson Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Mental Illness Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Mental Illness Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Mental Illness Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eli Lilly Mental Illness Drugs Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Mental Illness Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GlaxoSmithKline Mental Illness Drugs Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Mental Illness Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 AstraZeneca Mental Illness Drugs Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Mental Illness Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bristol-Myers Squibb Mental Illness Drugs Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments/Updates
7 Mental Illness Drugs Manufacturing Cost Analysis
7.1 Mental Illness Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Mental Illness Drugs
7.4 Mental Illness Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Mental Illness Drugs Distributors List
8.3 Mental Illness Drugs Customers
9 Mental Illness Drugs Market Dynamics
9.1 Mental Illness Drugs Industry Trends
9.2 Mental Illness Drugs Market Drivers
9.3 Mental Illness Drugs Market Challenges
9.4 Mental Illness Drugs Market Restraints
10 Global Market Forecast
10.1 Mental Illness Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Mental Illness Drugs by Type (2023-2030)
10.1.2 Global Forecasted Revenue of Mental Illness Drugs by Type (2023-2030)
10.2 Mental Illness Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Mental Illness Drugs by Application (2023-2030)
10.2.2 Global Forecasted Revenue of Mental Illness Drugs by Application (2023-2030)
10.3 Mental Illness Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Mental Illness Drugs by Region (2023-2030)
10.3.2 Global Forecasted Revenue of Mental Illness Drugs by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Mental Illness Drugs Sales Growth Rate Comparison by Type (2023-2030) & (K Units) & (US$ Million)
Table 2. Global Mental Illness Drugs Sales Growth Rate Comparison by Application (2023-2030) & (K Units) & (US$ Million)
Table 3. Global Mental Illness Drugs Market Size by Region (US$ Million) (2018 VS 2022 VS 2030)
Table 4. Global Mental Illness Drugs Market Competitive Situation by Manufacturers in 2022
Table 5. Global Mental Illness Drugs Sales (K Units) of Key Manufacturers (2018-2023)
Table 6. Global Mental Illness Drugs Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Mental Illness Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 8. Global Mental Illness Drugs Revenue Share by Manufacturers (2018-2023)
Table 9. Global Market Mental Illness Drugs Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 10. Manufacturers Mental Illness Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Mental Illness Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Mental Illness Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mental Illness Drugs as of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Mental Illness Drugs Sales by Region (2018-2023) & (K Units)
Table 16. Global Mental Illness Drugs Sales Market Share by Region (2018-2023)
Table 17. Global Mental Illness Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 18. Global Mental Illness Drugs Revenue Market Share by Region (2018-2023)
Table 19. North America Mental Illness Drugs Sales by Country (2018-2023) & (K Units)
Table 20. North America Mental Illness Drugs Sales Market Share by Country (2018-2023)
Table 21. North America Mental Illness Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 22. North America Mental Illness Drugs Revenue Market Share by Country (2018-2023)
Table 23. Europe Mental Illness Drugs Sales by Country (2018-2023) & (K Units)
Table 24. Europe Mental Illness Drugs Sales Market Share by Country (2018-2023)
Table 25. Europe Mental Illness Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 26. Europe Mental Illness Drugs Revenue Market Share by Country (2018-2023)
Table 27. Asia Pacific Mental Illness Drugs Sales by Region (2018-2023) & (K Units)
Table 28. Asia Pacific Mental Illness Drugs Sales Market Share by Region (2018-2023)
Table 29. Asia Pacific Mental Illness Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 30. Asia Pacific Mental Illness Drugs Revenue Market Share by Region (2018-2023)
Table 31. Latin America Mental Illness Drugs Sales by Country (2018-2023) & (K Units)
Table 32. Latin America Mental Illness Drugs Sales Market Share by Country (2018-2023)
Table 33. Latin America Mental Illness Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Latin America Mental Illness Drugs Revenue Market Share by Country (2018-2023)
Table 35. Middle East and Africa Mental Illness Drugs Sales by Country (2018-2023) & (K Units)
Table 36. Middle East and Africa Mental Illness Drugs Sales Market Share by Country (2018-2023)
Table 37. Middle East and Africa Mental Illness Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 38. Middle East and Africa Mental Illness Drugs Revenue Market Share by Country (2018-2023)
Table 39. Global Mental Illness Drugs Sales by Type (2018-2023) & (K Units)
Table 40. Global Mental Illness Drugs Sales Market Share by Type (2018-2023)
Table 41. Global Mental Illness Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 42. Global Mental Illness Drugs Revenue Share by Type (2018-2023)
Table 43. Global Mental Illness Drugs Price by Type (2018-2023) & (USD/Unit)
Table 44. Global Mental Illness Drugs Sales (K Units) by Application (2018-2023)
Table 45. Global Mental Illness Drugs Sales Market Share by Application (2018-2023)
Table 46. Global Mental Illness Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Mental Illness Drugs Revenue Share by Application (2018-2023)
Table 48. Global Mental Illness Drugs Price by Application (2018-2023) & (USD/Unit)
Table 49. Johnson and Johnson Corporation Information
Table 50. Johnson and Johnson Description and Business Overview
Table 51. Johnson and Johnson Mental Illness Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 52. Johnson and Johnson Mental Illness Drugs Product
Table 53. Johnson and Johnson Recent Developments/Updates
Table 54. Pfizer Corporation Information
Table 55. Pfizer Description and Business Overview
Table 56. Pfizer Mental Illness Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 57. Pfizer Mental Illness Drugs Product
Table 58. Pfizer Recent Developments/Updates
Table 59. Eli Lilly Corporation Information
Table 60. Eli Lilly Description and Business Overview
Table 61. Eli Lilly Mental Illness Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 62. Eli Lilly Mental Illness Drugs Product
Table 63. Eli Lilly Recent Developments/Updates
Table 64. GlaxoSmithKline Corporation Information
Table 65. GlaxoSmithKline Description and Business Overview
Table 66. GlaxoSmithKline Mental Illness Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 67. GlaxoSmithKline Mental Illness Drugs Product
Table 68. GlaxoSmithKline Recent Developments/Updates
Table 69. AstraZeneca Corporation Information
Table 70. AstraZeneca Description and Business Overview
Table 71. AstraZeneca Mental Illness Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 72. AstraZeneca Mental Illness Drugs Product
Table 73. AstraZeneca Recent Developments/Updates
Table 74. Bristol-Myers Squibb Corporation Information
Table 75. Bristol-Myers Squibb Description and Business Overview
Table 76. Bristol-Myers Squibb Mental Illness Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. Bristol-Myers Squibb Mental Illness Drugs Product
Table 78. Bristol-Myers Squibb Recent Developments/Updates
Table 79. Production Base and Market Concentration Rate of Raw Material
Table 80. Key Suppliers of Raw Materials
Table 81. Mental Illness Drugs Distributors List
Table 82. Mental Illness Drugs Customers List
Table 83. Mental Illness Drugs Market Trends
Table 84. Mental Illness Drugs Market Drivers
Table 85. Mental Illness Drugs Market Challenges
Table 86. Mental Illness Drugs Market Restraints
Table 87. Global Mental Illness Drugs Sales Forecast by Type (2023-2030) & (K Units)
Table 88. Global Mental Illness Drugs Sales Market Share Forecast by Type (2023-2030)
Table 89. Global Mental Illness Drugs Revenue Forecast by Type (2023-2030) & (US$ Million)
Table 90. Global Mental Illness Drugs Revenue Market Share Forecast by Type (2023-2030)
Table 91. Global Mental Illness Drugs Sales Forecast by Application (2023-2030) & (K Units)
Table 92. Global Mental Illness Drugs Sales Market Share Forecast by Application (2023-2030)
Table 93. Global Mental Illness Drugs Revenue Forecast by Application (2023-2030) & (US$ Million)
Table 94. Global Mental Illness Drugs Revenue Market Share Forecast by Application (2023-2030)
Table 95. Global Mental Illness Drugs Sales Forecast by Region (2023-2030) & (K Units)
Table 96. Global Mental Illness Drugs Sales Market Share Forecast by Region (2023-2030)
Table 97. Global Mental Illness Drugs Revenue Forecast by Region (2023-2030) & (US$ Million)
Table 98. Global Mental Illness Drugs Revenue Market Share Forecast by Region (2023-2030)
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Mental Illness Drugs
Figure 2. Global Mental Illness Drugs Market Share by Type in 2022 & 2030
Figure 3. Antipsychotics Product Picture
Figure 4. Antidepressants Product Picture
Figure 5. Antianxiety (anxiolyitcs) Product Picture
Figure 6. Anti-seizure medications Product Picture
Figure 7. Stimulants Product Picture
Figure 8. Cognitive disorders and dementia Product Picture
Figure 9. Sleep disorder treatments Product Picture
Figure 10. Substance abuse treatments Product Picture
Figure 11. Global Mental Illness Drugs Market Share by Application in 2022 & 2030
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Drugstore
Figure 15. Global Mental Illness Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2030
Figure 16. Global Mental Illness Drugs Market Size (2018-2030) & (US$ Million)
Figure 17. Global Mental Illness Drugs Sales (2018-2030) & (K Units)
Figure 18. Mental Illness Drugs Sales Share by Manufacturers in 2022
Figure 19. Global Mental Illness Drugs Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Mental Illness Drugs Players: Market Share by Revenue in 2022
Figure 21. Mental Illness Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Mental Illness Drugs Sales Market Share by Region (2018-2023)
Figure 23. Global Mental Illness Drugs Sales Market Share by Region in 2022
Figure 24. Global Mental Illness Drugs Revenue Market Share by Region (2018-2023)
Figure 25. Global Mental Illness Drugs Revenue Market Share by Region in 2022
Figure 26. U.S. Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 27. Canada Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 28. Germany Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 29. France Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 30. U.K. Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 31. Italy Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 32. Russia Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 33. China Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 34. Japan Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 35. South Korea Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 36. India Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 37. Australia Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 38. Taiwan Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 39. Indonesia Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 40. Thailand Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 41. Malaysia Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 42. Philippines Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 43. Vietnam Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 44. Mexico Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 45. Brazil Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 46. Argentina Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 47. Turkey Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 48. Saudi Arabia Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 49. U.A.E Mental Illness Drugs Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 50. Sales Market Share of Mental Illness Drugs by Type (2018-2023)
Figure 51. Manufacturing Cost Structure of Mental Illness Drugs
Figure 52. Manufacturing Process Analysis of Mental Illness Drugs
Figure 53. Mental Illness Drugs Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Industry Market Size
